SEMONE: Seniors Guardian: A Monitoring Platform for the Elderly

Sponsor
Universidad de Valparaiso (Other)
Overall Status
Completed
CT.gov ID
NCT03891771
Collaborator
Servicio de Vivienda y Urbanismo, Chile (Other), Ilustre Municipalidad de San Antonio, Chile (Other), Corporación Municipal de Valparaíso, Chile (Other)
69
4
2
25.2
17.3
0.7

Study Details

Study Description

Brief Summary

This pilot study evaluates whether a telemonitoring platform of activities of daily living amongst the elderly can improve their quality of life. Participants will be randomised to two different follow-up strategies, one comprising a monitoring platform and the other standard visits at a healthcare facility. Quality of life will be assessed using standardised questionnaires.

Condition or Disease Intervention/Treatment Phase
  • Device: Telemonitoring sensors
N/A

Detailed Description

Elderly participants at perceived socioeconomic risk will be randomised in a 1:1 ratio to receive either a telemonitoring platform in their houses or standard health care. The platform will include sensors able to detect falls, nocturia (which have been previously validated) and sensors for environmental variables including humidity, carbon monoxide levels and temperature. In addition, a wearable panic button will be provided for participants allocated to the sensor platform which will allow them to obtain help in case of an emergency. The sensor platform will be connected to emergency services and healthcare providers,and they should receive and react to any anomaly detected in their readings.

Participants will be followed up for 10 months. Quality of life questionnaires, including the World Health Organisation's WHOQOL-BREF and the EQ-5D for health-related quality of life, will be used to address potential intervention effects.

Study Design

Study Type:
Interventional
Actual Enrollment :
69 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
Seniors Guardian: A Non-intrusive Monitoring Platform for Activities of Daily Living Amongst the Elderly
Actual Study Start Date :
Apr 30, 2019
Actual Primary Completion Date :
Jun 6, 2021
Actual Study Completion Date :
Jun 6, 2021

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Usual Care

Patients allocated to usual care will receive standard follow-up procedures at their primary care facility.

Experimental: Telemonitoring sensors

Patients allocated to this arm will receive a complex sensor platform aimed at detecting falls at home, nocturia and several environmental variables, including carbon monoxide concentrations, humidity and temperature. The system also includes a panic button that can be used to request assistance in emergencies.

Device: Telemonitoring sensors
This complex platform entails several sensors aimed at detecting falls, nocturia and environmental variables in the participant's home. Sensors are non-intrusive and its only wearable component is the panic button which must be carried by the participant.

Outcome Measures

Primary Outcome Measures

  1. Overall Quality of Life score as measured by the World Health Organisation Quality of Life Questionnaire (WHOQOL-BREF) [1 month after randomisation]

    This scale is designed to assess the overall quality of life of the respondent using 5-point Likert scales. Higher scores mean a better quality of life. WHOQOL-BREF is divided in 4 domains, including physical health, psychological, social relationships and environment. The mean score for each domain is used to calculate the domain score. Scores can then be added together to obtain an overall score. Therefore, scores in the WHOQOL-BREF questionnaire range from 4 to 20 points.

  2. Overall Quality of Life score as measured by the World Health Organisation Quality of Life Questionnaire (WHOQOL-BREF) [5 months after randomisation]

    This scale is designed to assess the overall quality of life of the respondent using 5-point Likert scales. Higher scores mean a better quality of life. WHOQOL-BREF is divided in 4 domains, including physical health, psychological, social relationships and environment. The mean score for each domain is used to calculate the domain score. Scores can then be added together to obtain an overall score. Therefore, scores in the WHOQOL-BREF questionnaire range from 4 to 20 points.

  3. Overall Quality of Life score as measured by the World Health Organisation Quality of Life Questionnaire (WHOQOL-BREF) [10 months after randomisation]

    This scale is designed to assess the overall quality of life of the respondent using 5-point Likert scales. Higher scores mean a better quality of life. WHOQOL-BREF is divided in 4 domains, including physical health, psychological, social relationships and environment. The mean score for each domain is used to calculate the domain score. Scores can then be added together to obtain an overall score. Therefore, scores in the WHOQOL-BREF questionnaire range from 4 to 20 points.

  4. Health-Related Quality of Life score using the EuroQOL-5D (EQ-5D) Questionnaire [1 month after randomisation]

    EuroQol-5D (EQ-5D) is a standardised questionnaire that allows to quantify health-related quality of life. It is divided in two sections, a descriptive section and a visual analogue scale (VAS) at the end of the questionnaire. The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. The EQ-VAS records the patient's self-rated health on a vertical visual analogue scale. Results are presented as a descriptive profile or as an index value calculated from the descriptive component which is country-specific. Visual analog values can range from 0 to 100, with higher values indicating an overall better health-related quality of life.

  5. Health-Related Quality of Life score using the EuroQOL-5D (EQ-5D) Questionnaire [5 months after randomisation]

    EuroQol-5D (EQ-5D) is a standardised questionnaire that allows to quantify health-related quality of life. It is divided in two sections, a descriptive section and a visual analogue scale (VAS) at the end of the questionnaire. The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. The EQ-VAS records the patient's self-rated health on a vertical visual analogue scale. Results are presented as a descriptive profile or as an index value calculated from the descriptive component which is country-specific. Visual analog values can range from 0 to 100, with higher values indicating an overall better health-related quality of life.

  6. Health-Related Quality of Life score using the EuroQOL-5D (EQ-5D) Questionnaire [10 months after randomisation]

    EuroQol-5D (EQ-5D) is a standardised questionnaire that allows to quantify health-related quality of life. It is divided in two sections, a descriptive section and a visual analogue scale (VAS) at the end of the questionnaire. The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. The EQ-VAS records the patient's self-rated health on a vertical visual analogue scale. Results are presented as a descriptive profile or as an index value calculated from the descriptive component which is country-specific. Visual analog values can range from 0 to 100, with higher values indicating an overall better health-related quality of life.

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Elderly participant (>65 years of age) perceived to be at socioeconomic risk

  • Resident in the city of Valparaiso or San Antonio

  • Lives alone

  • Obtained a housing subsidy from the Servicio de Vivienda y Urbanismo (Housing and Urbanism Services)

Exclusion Criteria:
  • Dementia

  • Substance or alcohol abuse

  • Inability to answer quality of life questionnaires due to medical or psychiatric morbidity

  • Terminal illness (life expectancy under 6 months)

  • Ownership of pets within the residence (ie. dogs, cats).

  • Refusal to participate

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centro de Salud Familiar 30 de Marzo San Antonio Chile
2 Centro de Salud Familiar Barrancas San Antonio Chile
3 Centro de Salud Familiar Nestor Fernandez San Antonio Chile
4 Centro de Salud Familiar San Antonio San Antonio Chile

Sponsors and Collaborators

  • Universidad de Valparaiso
  • Servicio de Vivienda y Urbanismo, Chile
  • Ilustre Municipalidad de San Antonio, Chile
  • Corporación Municipal de Valparaíso, Chile

Investigators

  • Study Chair: Carla Taramasco, Ph.D., Universidad de Valparaiso
  • Principal Investigator: Felipe T Martinez, M.D., M.Sc, Universidad Andres Bello

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
Universidad de Valparaiso
ClinicalTrials.gov Identifier:
NCT03891771
Other Study ID Numbers:
  • CEC181-18
First Posted:
Mar 27, 2019
Last Update Posted:
Nov 22, 2021
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Universidad de Valparaiso

Study Results

No Results Posted as of Nov 22, 2021